bioXXmed AG (XTER:T5O0) Net Change in Cash : €22.78 Mil (TTM As of Jun. 2024)

View and export this data going back to 2006. Start your Free Trial

What is bioXXmed AG Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

bioXXmed AG's Net Change in Cash for the six months ended in Jun. 2024 was €-51.81 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 was €22.78 Mil.

bioXXmed AG Net Change in Cash Historical Data

The historical data trend for bioXXmed AG's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

bioXXmed AG Net Change in Cash Chart

bioXXmed AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

-0.68

-0.44

-1.69

1.68

-1.23

bioXXmed AG Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Net Change in Cash	Get a 7-Day Free Trial															196.11	-194.43	-75.82	74.59	-51.81

bioXXmed AG Net Change in Cash Calculation

bioXXmed AG's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-0.73	+	-0.504	+	0	+	0
	=	-1.23

bioXXmed AG's Net Change in Cash for the quarter that ended in Jun. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -48.96 + -2.85 + 0 + 0

= -51.81

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €22.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

bioXXmed AG Net Change in Cash Related Terms
Thank you for viewing the detailed overview of bioXXmed AG's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

bioXXmed AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » bioXXmed AG (XTER:T5O0) » Definitions » Net Change in Cash

Comparable Companies

XMAD:BKT XMAD:BBVA XMAD:SAB XMAD:SAN XMAD:UNI OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB XKRX:068270

Traded in Other Exchanges

T5O0:Germany T5O0:Germany

Address

Riedstrasse 2, Darmstadt, HE, DEU, 64295

Website

https://www.bioxxmed.ag

bioXXmed AG is an investment and holding company in the technology sector. It originated from CytoTools GmbH, a successful German technology enterprise from the pharmaceuticals and medical products field.

bioXXmed AG Headlines

No Headlines